Literature DB >> 21538356

Long-term survival after esophagectomy for early esophageal squamous cell carcinoma in Linxian, China.

Philip I Song1, Hao Liang, Jin-Hu Fan, Wen-Qiang Wei, Guo-Qing Wang, You-Lin Qiao.   

Abstract

BACKGROUND AND OBJECTIVES: Linxian in Henan Province, China, has among the highest rates of esophageal cancer worldwide. Little is known about long-term survival after esophagectomy for early neoplastic lesions found during early detection screening. A long-term survival analysis was performed for 315 patients from Linxian who received esophagectomy for early esophageal squamous cell carcinoma (ESCC).
METHODS: Cases that received esophagectomy for early ESCC were age- and gender-matched with two healthy controls, and Kaplan-Meier survival analyses were performed for both groups.
RESULTS: Ten-year survival was 77% for cases and 64% for controls, and this difference was not statistically significant (P = 0.33). There were no significant differences in survival based on age or gender (P > 0.05). Cases with ESCC in situ had significantly better survival than cases with invasive ESCC (P = 0.035).
CONCLUSIONS: Survival of cases who received esophagectomy for early ESCC was not significantly different from survival of age- and gender-matched controls. Early intervention probably improved survival rates for these patients who otherwise would most likely have developed advanced esophageal carcinoma. Early screening and intervention are highly relevant in areas with a high risk of esophageal cancer such as Linxian, China.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21538356      PMCID: PMC3129477          DOI: 10.1002/jso.21953

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  18 in total

1.  The strategy for esophageal cancer control in high-risk areas of China.

Authors:  Zhiwei Dong; Pingzhang Tang; Liandi Li; Guoqing Wang
Journal:  Jpn J Clin Oncol       Date:  2002-03       Impact factor: 3.019

Review 2.  Surgical management of esophageal carcinoma.

Authors:  C E Reed
Journal:  Oncologist       Date:  1999

Review 3.  Esophageal cancer.

Authors:  Peter C Enzinger; Robert J Mayer
Journal:  N Engl J Med       Date:  2003-12-04       Impact factor: 91.245

4.  Effect of surgical experience on results of esophagectomy for esophageal carcinoma.

Authors:  J D Miller; M K Jain; C J de Gara; D Morgan; J D Urschel
Journal:  J Surg Oncol       Date:  1997-05       Impact factor: 3.454

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening.

Authors:  Guo-Qing Wang; Guang-Gen Jiao; Fu-Bao Chang; Wei-Hong Fang; Jin-Xiang Song; Ning Lu; Dong-Mei Lin; Yong-Qiang Xie; Ling Yang
Journal:  Ann Thorac Surg       Date:  2004-05       Impact factor: 4.330

7.  Epidemiology of esophageal cancer in China.

Authors:  J Y Li
Journal:  Natl Cancer Inst Monogr       Date:  1982

8.  High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy.

Authors:  James R Headrick; Francis C Nichols; Daniel L Miller; Mark S Allen; Victor F Trastek; Claude Deschamps; Cathy D Schleck; Ann M Thompson; Peter C Pairolero
Journal:  Ann Thorac Surg       Date:  2002-06       Impact factor: 4.330

9.  Results of esophagectomy for esophageal cancer in elderly patients: age has little influence on outcome and survival.

Authors:  Alberto Ruol; Giuseppe Portale; Giovanni Zaninotto; Matteo Cagol; Francesco Cavallin; Carlo Castoro; Vanna Chiarion Sileni; Rita Alfieri; Sabrina Rampado; Ermanno Ancona
Journal:  J Thorac Cardiovasc Surg       Date:  2007-05       Impact factor: 5.209

10.  Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial.

Authors:  You-Lin Qiao; Sanford M Dawsey; Farin Kamangar; Jin-Hu Fan; Christian C Abnet; Xiu-Di Sun; Laura Lee Johnson; Mitchell H Gail; Zhi-Wei Dong; Binbing Yu; Steven D Mark; Philip R Taylor
Journal:  J Natl Cancer Inst       Date:  2009-03-24       Impact factor: 13.506

View more
  6 in total

1.  Cellular changes in the tumor microenvironment of human esophageal squamous cell carcinomas.

Authors:  Jinzhong Liu; Zhenfeng Li; Jing Cui; Gang Xu; Guanglin Cui
Journal:  Tumour Biol       Date:  2011-12-02

2.  Identification of glutathione S-transferase omega 1 (GSTO1) protein as a novel tumor-associated antigen and its autoantibody in human esophageal squamous cell carcinoma.

Authors:  Yang Li; Qi Zhang; Bo Peng; Qing Shao; Wei Qian; Jian-Ying Zhang
Journal:  Tumour Biol       Date:  2014-08-02

3.  Long-term outcomes of an esophagus-preserving chemoradiotherapy strategy for patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma.

Authors:  Tatsuya Suwa; Yuichi Ishida; Yoshiharu Negoro; Fusako Kusumi; Yoshio Kadokawa; Rihito Aizawa; Toshifumi Nakajima; Yoshiaki Okamoto; Yoshishige Okuno; Kazunari Yamada; Masakazu Ogura; Masao Murakami; Takashi Mizowaki
Journal:  Clin Transl Radiat Oncol       Date:  2021-08-11

4.  Differential expression of miRNAs in esophageal cancer tissue.

Authors:  Shang-Guo Liu; Xiu-Guang Qin; Bao-Sheng Zhao; Bo Qi; Wen-Jian Yao; Tian-Yun Wang; Han-Chen Li; Xiang-Nan Wu
Journal:  Oncol Lett       Date:  2013-03-12       Impact factor: 2.967

5.  The Relationship between Social Support and Quality of Life: Evidence from a Prospective Study in Chinese Patients with Esophageal Carcinoma.

Authors:  Yanjie Wang; Lili Zhu; Fang Yuan; Lixia Kang; Zhen Jia; Dongming Chen; Ping Zhang; Zhanchun Feng
Journal:  Iran J Public Health       Date:  2015-12       Impact factor: 1.429

Review 6.  Esophageal cancer with a double aortic arch: a case report and literature review.

Authors:  Kai Kang; Sheng Wang; Fei Xiong; Jindan Kai; Jianjian Wang; Binfeng Li
Journal:  J Cardiothorac Surg       Date:  2022-03-11       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.